Dec 14 (Reuters) - Sio Gene Therapies Inc SIOX.O :
* SIO GENE THERAPIES INC. ANNOUNCES BOARD APPROVAL OF PLAN
OF
COMPLETE LIQUIDATION AND DISSOLUTION
* SIO GENE THERAPIES - CO INTENDS TO CALL SPECIAL MEETING OF
ITS
SHAREHOLDERS IN FIRST CALENDAR QUARTER OF 2023 TO SEEK APPROVAL
OF PLAN OF DISSOLUTION
* SIO GENE THERAPIES INC - CO WILL ESTABLISH A RESERVE,
WHICH WILL
BE USED TO PAY ALL EXPENSES
* SIO GENE THERAPIES - BOARD DETERMINED THAT IT IS IN BEST
INTERESTS OF CO TO DISSOLVE COMPANY AND LIQUIDATE ITS ASSETS,
INCLUDING ITS SUBSIDIARIES
* SIO GENE THERAPIES - CO WILL ESTABLISH A RESERVE TO BE
USED TO
PAY ALL EXPENSES AND OTHER KNOWN, NON- CONTINGENT LIABILITIES
AND OBLIGATIONS
Source text for Eikon: ID:nGNX5rTyHz
Further company coverage: SIOX.O
((Reuters.Briefs@thomsonreuters.com;))